Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

65.10
Delayed Data
As of 3:59pm ET
 +0.72 / +1.12%
Today’s Change
47.92
Today|||52-Week Range
103.29
-20.51%
Year-to-Date

Today’s Trading

Previous close64.38
Today’s open64.12
Day’s range63.59 - 65.89
Volume805,112
Average volume (3 months)908,813
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-30.77%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book23.78

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.65+0.91%
ABMDAbiomed Inc+2.12+2.18%
NUVANuVasive Inc-0.33-0.62%
IARTIntegra LifeSciences...+0.94+1.33%
Data as of 4:02pm ET, 05/02/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Chief Operating Officer &
Director
Kevin Ronald Sayer
Chief Financial Officer &
Senior Vice President
Jess Roper
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs